Daiichi Sankyo gets approval for additional indication of Antiplatelet Agent Efient in Japan Ruchika Sharma27 Dec 2021 5:38 PM ISTTokyo: Daiichi Sankyo Company, Limited has announced that the company has obtained a supplemental new drug application approval for additional...
SC asks Fortis to submit details of Rs 4000 crores IHH deal, Singh brothers role by March 1 MD Bureau26 Feb 2021 9:30 AM ISTNew Delhi: In the latest update regarding the Fortis Healthcare Row, the Supreme Court of India, on Wednesday, has asked the company to provide the...
Daiichi Sankyo names Ken Takeshita as Global Head of RnD Ruchika Sharma24 Feb 2021 2:48 PM ISTTokyo & Munich & Basking Ridge, N.J.: Daiichi Sankyo Company, Limited has recently announced Ken Takeshita, MD will be named the new Global...
SC asks 17 lenders To Place Loan Records Of Singh brothers, Fortis Healthcare MD Bureau23 Feb 2021 10:00 AM ISTNew Delhi: The Supreme Court has asked 17 lenders, banks and financial institutions to place on record the basic documents pertaining to loans...
COVID-19 Vaccine: AstraZeneca AZD1222 phase 1/2 trials to begin in Japan Ruchika Sharma6 Sept 2020 9:15 AM ISTTokyo: Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate.Trials of the vaccine, known...
Daiichi Sankyo Plea: Delhi HC issues notice to Singh Brothers, next hearing on July 28 Farhat Nasim25 Jun 2020 5:13 PM ISTDaiichi's counsel senior advocate Arvind Nigam contended that as per an affidavit filed by the respondent the mark is essential. It was submitted that...
SETBACK: Singapore SC junks Singh Brothers plea against Rs 3500 crore arbitral award in Daiichi Case Farhat Nasim1 Jun 2020 11:56 AM ISTNew Delhi: In a major setback to Singh Brothers, the Singapore Court of Appeals on May 28 junked the petition filed by the former Ranbaxy promoters,...
Daiichi Sankyo Launches ENHERTU in Japan for Patients with HER2 Positive Unresectable or Metastatic Breast Cancer Ruchika Sharma26 May 2020 12:53 PM ISTTokyo, Munich: Daiichi Sankyo Company, Limited has announced the launch of ENHERTU® (trastuzumab deruxtecan), a HER2 directed antibody drug conjugate...
AstraZeneca, Daiichi Sankyo get Orphan Drug Designation for gastric cancer drug Enhertu Ruchika Sharma25 May 2020 11:56 AM ISTUS: Daiichi Sankyo Company Limited and AstraZeneca's Enhertu (trastuzumab deruxtecan) has been granted Orphan Drug Designation (ODD) in the US for the...
Daiichi-Ranbaxy row: HC allows the sale of Singh brothers' firms to repay the Rs 3,500 crore arbitration award Medical Dialogues Bureau24 Feb 2020 5:34 PM ISTNew Delhi: The Delhi High Court today allowed the sale of unencumbered shares of the firms of former promoters of India's Ranbaxy Laboratories Ltd in...
Singh brothers directed to give Rs 1175 crore payment in Daiichi Sankyo case, given timeline Farhat Nasim3 Feb 2020 5:32 PM ISTNew Delhi: Former Fortis Healthcare promoters, Malvinder Mohan Singh and Shivinder Mohan Singh (Singh Brothers) have been directed today by the...
Singh Brothers held guilty of contempt by Supreme Court Garima15 Nov 2019 9:00 AM ISTA bench comprising Chief Justice Ranjan Gogoi and Justice Deepak Gupta held the former Ranbaxy promoters guilty of contempt of court and said that...
